[Retracted] SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma

Figure 4

The expression of LOC101060391 and SFRP2 in PA and their diagnostic value. ((a) and (b)) The expression of LOC101060391 and SFRP2 was distinctly increased in PA specimens compared with nontumor specimens from GSE26966 and GSE63357 datasets. ((c) and (d)) ROC assays confirmed the diagnostic value of LOC101060391 and SFRP2 for PA based on GSE26966 and GSE63357 datasets.

(a)

(b)

(c)

(d)